Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$69.73 - $142.9 $486,994 - $998,013
-6,984 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$134.56 - $217.97 $720,165 - $1.17 Million
5,352 Added 327.94%
6,984 $999,000
Q3 2021

Nov 15, 2021

SELL
$177.8 - $270.58 $1,422 - $2,164
-8 Reduced 0.49%
1,632 $338,000
Q2 2021

Aug 16, 2021

BUY
$121.0 - $257.67 $198,440 - $422,578
1,640 New
1,640 $348,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $770M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.